← Back to Search

Labor Management Guidelines for Difficult Labor (REDUCED Trial)

N/A
Recruiting
Led By Stephen Wood, MD MSc
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Centers in Alberta that provide intrapartum care, have facilities to perform cesarean section and deliver at least 70 primparous women annually
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 30 days of delivery
Awards & highlights
No Placebo-Only Group

Summary

This trial tests an intervention to reduce c-sections in first-time moms, without increasing harm to mother/baby, and is based on data from the Consortium for Safe Labor.

Who is the study for?
The REDUCED Trial is for first-time mothers at term (>= 37 weeks) with a baby in head-down position, delivering in Alberta centers that can perform cesarean sections and care during labor. Centers must handle over 70 such births yearly to participate.
What is being tested?
This trial tests the effectiveness of sharing new guidelines on managing difficult labor among healthcare providers. The goal is to lower cesarean section rates without increasing risks to mother or baby by using data-driven management practices.
What are the potential side effects?
Since this trial involves the implementation of knowledge rather than medication, there are no direct side effects from drugs. However, changes in labor management could potentially affect delivery experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days of delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 days of delivery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of Cesarean section
Secondary study objectives
Rate of blood transfusion
Rate of moderate or severe asphyxia or meets criteria for therapeutic cooling
Asphyxia Neonatorum
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention centersExperimental Treatment1 Intervention
Application of a knowledge translation strategy, of new clinical practice guidelines on labor management, to physicians and nurses caring for women in labor. Intervention centers will receive knowledge translation of labor management guidelines
Group II: Control centersActive Control1 Intervention
No intervention at control centers

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
809 Previous Clinical Trials
786,383 Total Patients Enrolled
Stephen Wood, MD MScPrincipal InvestigatorUniversity of Calgary

Media Library

Knowledge Translation of labor management guidelines Clinical Trial Eligibility Overview. Trial Name: NCT02874443 — N/A
Cesarean Section Research Study Groups: Intervention centers, Control centers
Cesarean Section Clinical Trial 2023: Knowledge Translation of labor management guidelines Highlights & Side Effects. Trial Name: NCT02874443 — N/A
Knowledge Translation of labor management guidelines 2023 Treatment Timeline for Medical Study. Trial Name: NCT02874443 — N/A
~3000 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top